SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-17-015335
Filing Date
2017-08-25
Accepted
2017-08-25 16:32:22
Documents
2
Period of Report
2017-08-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 2866
2 EX-24 - POWER OF ATTORNEY EXHIBIT poa_cohen.htm EX-24 8019
  Complete submission text file 0001437749-17-015335.txt   12296
Mailing Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241
Business Address 2500 CROSSPARK ROAD, SUITE E126 CORALVILLE IA 52241 319-665-2575
KEMPHARM, INC (Issuer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2656 CROSSPARK ROAD, SUITE 100 CORALVILLE IA 52241
Business Address
Cohen Daniel L (Reporting) CIK: 0001672300 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36913 | Film No.: 171052355